Skip to main content

TUDOR INVESTMENT CORP ET AL

Position in ROIV — Roivant Sciences Ltd.

CIK 923093 STAMFORD, CT

Position in ROIV

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2022
14 quarters on record

Common Shares in ROIV Over Time

Shares Held

Position Value (USD)

Derivatives in ROIV

reported options exposure · as of Jun 30, 2026
CallValue
$2,717,952
CallShares
76,800
PutValue
$647,637
PutShares
18,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TUDOR INVESTMENT CORP ET AL holds $411,209,149 across 107 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in ROIV

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $647,637 18,300
2026-06-30 $2,717,952 76,800
2026-03-31 $260,380 9,400
2026-03-31 $229,910 8,300
2025-12-31 $755,160 34,800
2025-12-31 $249,550 11,500
2025-09-30 $266,288 17,600
2025-06-30 $859,472 76,262
2024-06-30 $534,831 50,599
2024-03-31 $1,828,848 173,515
2023-12-31 $3,296,173 293,515
2023-09-30 $2,099,199 179,726
2023-06-30 $3,332,357 330,591
2023-03-31 $2,834,680 384,103
2022-12-31 $1,372,266 171,748
2022-09-30 $1,140,198 354,099
2022-06-30 $246,804 60,640